Three patients with severe vision impairment received stem cell transplants, showing remarkable, lasting improvements in eyesight, marking a significant breakthrough in treating LSCD.
Kapil Bharti from the NIH described the results as "an exciting development," suggesting that such advancements in stem cell treatment present promising prospects for other patients.
Jeanne Loring from Scripps Research emphasized that "the results merit treating more patients," highlighting the potential of stem-cell therapies in restoring vision.
The study indicates reprogrammed stem cells from induced pluripotent sources could provide an innovative alternative for corneal transplants, especially for patients with LSCD.
#stem-cells #vision-improvement #corneal-transplants #limbal-stem-cell-deficiency #research-advancement
Collection
[
|
...
]